Loading company…
Reforgene develops gene and cell therapy drugs and provides related research and evaluation services.
Founded in 2019 and based in Guangzhou, China, Reforgene develops gene and cell therapy drugs for conditions including thalassemia and malignant tumors. It also provides gene editing, drug strategy, animal model, and efficacy and safety evaluation services. In December 2024, it closed a venture funding round to support clinical trials, pipeline development, and technology work.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in